Mauna Kea Nixes Deal with Cook Medical
Citing a lack of commercial progress, Mauna Kea Technologies is calling off an agreement with Cook Medical that was signed a little over three years ago involving Mauna Kea's Cellvizio platform. Paris, France-based Mauna Kea said the decision to terminate the development and distribution agreements with Cook was mutual. Cook has not officially commented on the news. Cellvizio is a multidisciplinary probe and needle-based confocal laser endoscopy platform.Â The device enables direct visualization of human tissues at the cellular scale and allows doctors to detect anomalies invisible with standard techniques, part...
Source: MDDI - February 21, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal
Mauna Kea (ENT:MKEA) said today that it and Cook Medical have mutually decided to terminate their development and distribution agreement. The deal, originally inked in late 2015, included the development of Mauna Kea’s Cellvizio confocal laser endomicroscopy systems for urologic applications. Paris-based Mauna Kea said that it agreed to develop a private-label version of the Cellvizio with an emphasis on characterizing upper urinary tract urothelial cancer. “Mauna Kea was understandably excited by the prospect of combining our innovative, confocal laser endomicroscopy technology with an established medical...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Imaging Urology Cook Medical Mauna Kea Technologies Source Type: news
Selective cystoscopy during hysterectomy reduces costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2019 Category: Drugs & Pharmacology Source Type: news
FDA clears UVision360 hysteroscopy device
UVision360 said today it won FDA 510(k) clearance for its Luminelle DTx hysteroscopy system, now indicated for both hysteroscopy and cystoscopy. The Raleigh, N.C.-based company’s Luminelle DTx system is designed to allow physicians to see the internal lining of the uterus from an optimal distance to allow for the identification of suspicious tissue. The system also allows for biopsies to be performed under visualization, UVision said. “Since the best technology is typically only available in the operating room, many physicians and patients opt to skip the hysteroscopy and either perform a blind biopsy or go str...
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Women's Health uvision360 Source Type: news
Triad medical center plans to start construction on $31.5 million surgery center
Wake Forest Baptist Health-Lexington Medical Center plans to start construction on its $31.5 million surgery center in September. The 26,500-square-foot surgery center will be adjacent to the outpatient surgery center at the facility. Wake Forest Baptist Medical Center announced its plans for the center in April. The new facility will have four digital operating rooms, which will accommodate various types of procedures and specialities. The center also will have a cystoscopy procedure room, a… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 12, 2018 Category: Biotechnology Authors: Jessica Seaman Source Type: news
Urologists Practice Spotting Tumors With Virtual Reality Technology
BOSTON (CBS) – Virtual reality is being used in healthcare more, and a local company is using the technology to help doctors identify hard-to-see tumors in the bladder. Almost 80,000 Americans are diagnosed with bladder cancer every year. To find bladder tumors, a urologist looks directly at the inside of the bladder using a cystoscope, a small tube with a camera and light attached. Cystoscopes are equipped with technology called narrow band imaging. (WBZ-TV) Some tumors are harder to find. But to make it easier, many cystoscopes are equipped with technology called narrow band imaging (NBI). “What NBI does is i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 30, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Virtual Reality Source Type: news
Karl Storz Focuses on Bladder Cancer Detection With New Device
Karl Storz is focusing on bladder cancer detection with its latest product. The El Segunda, CA-based company said it is launching the PDD Blue Light Flexible Video Cytoscopy System. The product launch follows the approval of a supplemental new drug application and a premarket approval supplement from FDA extending the indication for Blue Light Cystoscopy with Cysview (BLCC) to include use of the new Karl Storz PDD Blue Light Flexible Video Cystoscope. Also included in the approval is an expanded indication for the repetitive use of Cysview within the same patient and for the identification of Carcinoma in Situ (CIS); one o...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
OSLO, Norway, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLC) with Cysview for a new indication of surveillance cystoscopy of bladder cancer. ... Devices, Diagnostics, Oncology, Product Launch Photocure, Karl Storz, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news
Laborie Medical closes $214m Cogentix buy
Laborie Medical Technologies said today that it closed the $214 million acquisition of Cogentix Medical (NSDQ:CGNT). With about 85% of the urology and gynecology device maker’s shares tendered over the weekend, meeting the minimum tender requirement, the stage was set for the deal to close today. The $3.85-per-share cash tender pulled in some 51.5 million shares, for about $198.2 million, Laborie said April 21. The deal represents a 14.2% premium over CGNT stock’s $3.37 closing price March 9, the last business day before the deal was announced. “Our combined, complementary pr...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Women's Health Cogentix Medical Laborie Medical Technologies Source Type: news
UroViu wins FDA nod for disposable diagnostic cytoscope
UroViu said yesterday it won FDA 510(k) clearance for its Uro-V single-use diagnostic cytoscopic system designed to visually assess the urethra and urinary bladder in instances of suspected pathology or dysfunction. The Bellevue, Wash.-based company’s newly cleared Uro-V device is a self-contained single-use diagnostic cytoscope designed for female diagnostic cytoscopy. The system is designed to be light-weight, portable and battery powered with a disposable cannula and a reusable handle, video processor, LCD display and touchscreen display. “Today’s growing and aging population faces a severe problem of ...
Source: Mass Device - March 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Urology uroviu Source Type: news
Response and Development of Immune-Related Adverse Events in an 83-Year-Old Man With Metastatic Urothelial Cancer
An 83-year-old man was diagnosed with multiple low-grade transitional cell carcinomas over a 6-year period. A surveillance cystoscopy in year 7 showed high-grade noninvasive papillary urothelial carcinoma in the bladder trigone. A CT urogram showed a soft-tissue mass with diffuse enhancement in the lower pole of the left kidney, concerning for malignancy. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Daniel P. Petrylak, MD Karishma K. Mehra, MD Tags: Bladder Cancer Genitourinary Cancers Oncology Journal Source Type: news
Laborie Set to Acquire Cogentix
Laborie Medical Technologies is set to acquire Cogentix Medical for about $239 million in a deal that will close in the second quarter of 2018. The price represents a 28% premium over Cogentix average 30-day closing price. Minnetonka, MN-based Cogentix specializes in urology devices. The firm’s products include Urgent PC, a neuromodulation system for percutaneous tibial nerve stimulation. It treats overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence on an outpatient basis. Join us at the BIOMEDevice Boston Expo, April 18–19, 2018. Use promo code "MD...
Source: MDDI - March 13, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Laborie Medical to pay $214m for Cogentix
Laborie Medical Technologies said today that it agreed to pay $214 million for Cogentix Medical (NSDQ:CGNT) and its line of urology and gynecology devices. Formed by the 2015 merger of Vision-Sciences and Uroplasty, Minnetonka, Minn.-based Cogentix makes the Urgent PC neuromodulation device for treating overactive bladder syndrome, the PrsimeSight cystoscopy and EndoSheath devices and Macroplastique, an injectable soft-tissue bulking agent for treating female stress urinary incontinence. The $3.85-per share cash offer is slated to close during the first half of the year, Toronto-based Lab...
Source: Mass Device - March 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Wall Street Beat Women's Health Cogentix Medical Laborie Medical Technologies Source Type: news
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
OSLO, Norway, Feb. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Lig... Devices, Oncology, FDA Photocure, KARL STORZ, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2018 Category: Pharmaceuticals Source Type: news
Urine test UroMark could save NHS millions
Developed by researchers at University College London, UroMark can detect bladder cancer in 98 per cent of cases, a figure equivalent to the results of cystoscopies. (Source: the Mail online | Health)
Source: the Mail online | Health - September 9, 2017 Category: Consumer Health News Source Type: news
Noninvasive Urine Test Predicts Bladder Cancer Recurrence Noninvasive Urine Test Predicts Bladder Cancer Recurrence
A new noninvasive test was more predictive of bladder cancer recurrence than standard cytology and cystoscopy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
What Causes Urinary Hesitancy?
Discussion “Hesitancy” denotes difficulty in initiating voiding when the child is ready to void,” according to the International Children’s Continence Society. It is not seen that often in pediatrics in isolation, but is commonly associated with other symptoms such as dysuria, frequency, abdominal or anal pain which may indicate common problems such as a urinary tract infection, vaginal/perineal irritation, or constipation. Communication problems can also confound the accuracy of the history as patients and families can have a difficult time describing the urinary problem they are experiencing or ma...
Source: PediatricEducation.org - June 19, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Penile fracture following a fall in a seven year old male - Meenakshi-Sundaram B, Coco CT, Furr JR, Shaw MD, Frimberger DC.
We report a rare case of isolated penile fracture in a prepubescent male caused by an accidental fall. The patient presented with swelling and ecchymosis on the base of the penis and along the penile shaft. A flexible cystoscopy was performed which did not... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Ultrasound plus cystoscopy cost effective for diagnosis of AMH
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2017 Category: Drugs & Pharmacology Source Type: news
Evaluation Strategies Compared in Microscopic Hematuria
U/S + cystoscopy most cost - effective of four approaches for asymptomatic microscopic hematuria (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 19, 2017 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nephrology, Nursing, Oncology, Urology, Journal, Source Type: news
Cystoscopy Plus Ultrasound Most Cost-effective for Microscopic Hematuria Evaluation Cystoscopy Plus Ultrasound Most Cost-effective for Microscopic Hematuria Evaluation
Cystoscopy coupled with renal ultrasound is the most cost-effective approach for the initial diagnostic evaluation of patients with asymptomatic microscopic hematuria (AMH), according to a new analysis online today in JAMA Internal Medicine.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2017 Category: Consumer Health News Tags: Radiology News Source Type: news
Should ultrasound replace CT for asymptomatic hematuria?
The combination of renal ultrasound and cystoscopy is the most cost-effective...Read more on AuntMinnie.comRelated Reading: Sharing best practices cuts CT dose substantially Blunt abdominopelvic trauma algorithm cuts CT use in ER Apply Formula 1-type methods to smooth the way in urogenital emergencies Study: Hold the contrast for CT of asymptomatic hematuria Study finds frequent incidental findings at MDCT urography (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2017 Category: Radiology Source Type: news
What Every Man Must Know About BPH
One of the most common conditions a man can get affecting his prostate is benign prostatic hyperplasia or BPH. BPH is an enlargement of the prostate putting pressure on the urethra making it difficult to urinate along with other symptoms associated with it. It becomes more prevalent as a man ages with the risk of BPH increasing each year after a man turns 40. By age 60, more than half of all men will have BPH and by age 85, about 90 percent of men have this condition. How will a man know if he has BPH? Most of the signs and symptoms of BPH are urinary related. The prostate gland, the size of a walnut, surrounds the urethra...
Source: Healthy Living - The Huffington Post - February 28, 2017 Category: Consumer Health News Source Type: news
Urine Assay Identifies Patients With Hematuria Who Do Not Require Cystoscopy Urine Assay Identifies Patients With Hematuria Who Do Not Require Cystoscopy
A new DNA methylation-mutation urine assay can be used to determine which patients with hematuria need to undergo cystoscopy, researchers report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 4, 2016 Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news
Bladder Stone Basics
Bladder stones are not often heard of as they are not nearly as common as kidney stones. Sometimes referred to as urinary tract stones or bladder calculi, they primarily affect men as 95% of all bladder stones cases are found in men. What are bladder stones? Bladder stones are formed when substances such as calcium oxalate concentrate in the urine turning into hard, solid lumps lodging in the bladder. It is more common to have several stones form at the same time. Urine is about 95% water with the other 5% containing minerals such as salt, and waste products such as protein. When the urine is concentrated, often due to ...
Source: Healthy Living - The Huffington Post - August 11, 2016 Category: Consumer Health News Source Type: news
Urine-Based DNA Test Can Help Diagnose Bladder Tumors
A novel urine-based DNA test was effective at detecting bladder cancer, and in particular at identifying patients with gross hematuria who do not require cystoscopy. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers News Source Type: news
What It Means When You See Blood In Your Urine
There are few moments more frightening than seeing blood in your urine. Happily, the cause is often not serious. The condition is more formally known as hematuria, and blood in the urine is usually the only symptom. Note that it does not take much blood to color urine pink or red, and the bleeding is usually not painful. Certain foods - notably rhubarb and beets - can also turn your urine a reddish color. In all instances of detecting blood in your urine, see a doctor. It is symptomatic of a number of ailments, including: • An enlarged prostate. As this gland begins to grow - commonly with the onset of middle age i...
Source: Healthy Living - The Huffington Post - July 27, 2016 Category: Consumer Health News Source Type: news
Schistosoma haematobium Infection That Mimics Bladder CancerSchistosoma haematobium Infection That Mimics Bladder Cancer
This patient's history of gross hematuria led to a suspicion of bladder cancer, but cystoscopic testing revealed a more unusual cause. Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline
PRINCETON, N.J., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Photocure Inc. announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016 Guidelines for th... Biopharmaceuticals, Diagnostics, Urology, OncologyPhotocure, cystoscopy, bladder cancer, Cysview, Hexvix (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 2, 2016 Category: Pharmaceuticals Source Type: news
Jett’s story: A second opinion and a second chance
Allie and Chris Taylor vividly remember the day their second son Jett was born. “Jett was a gift to me — the one I fought and cried for,” Allie recalls. Twenty weeks earlier, during a routine ultrasound conducted at a nearby hospital, Allie and Chris were told their unborn son’s kidneys were enlarged. Doctors feared the worst. “They did a second ultrasound and told us my baby wouldn’t make it past 28 weeks gestation. We were told we should see a specialist but not to keep our hopes high.” Allie and Chris were seen three days later at the Advanced Fetal Care Center at...
Source: Thrive, Children's Hospital Boston - December 15, 2015 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Department of Urology Dr. Richard Lee ureterocele vesicoureteral reflux (VUR) Source Type: news
Frieda the fibroid, and TAH with ovaries removed experience – Donna’s story
The post Frieda the fibroid, and TAH with ovaries removed experience – Donna’s story appeared first on Hysterectomy Association. I knew I had a fibroid along with a phobia surrounding doctors, needles, hospitals etc. At around 41 I started experiencing pressure in the abdomen and a need to urinate more frequently, I ignored it. A routine medical picked up blood in my urine which culminated in an ultrasound and a cystoscopy which resulted in Frieda the fibroid being found. The medical team said it could be that I would make it to menopause and Frieda would begin to shrink, at this stage she was around 5cm. At 49...
Source: The Hysterectomy Association - September 9, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories fibroids menopause Source Type: news
Candiru: a catfish that’s small, eel-like, and penetrates the urethra
3.5 out of 5 stars Candiru — A Little Fish With Bad Habits: Need Travel Health Professionals Worry? A Review. Bauer IL J Travel Med 2013 Mar-Apr;20:119-124. Abstract Don’t know how I missed this paper when it was published 2 years ago. The author searched medical literature to answer the pressing question: Is there really a catfish native to the Amazon River that can swim up — and become embedded in — a man’s urethra? TPR has posted on this subject before. The candiru (Vandellia cirrhosa) — a tiny eel-like catfish — is a blood-sucking parasite that preys on larger fish, following t...
Source: The Poison Review - August 12, 2015 Category: Toxicology Authors: Leon Tags: Medical candiru catfish penis urethral penetration urology Source Type: news
First bladder cancer guideline to reduce variations in care
NICE recommends that when diagnosing bladder cancer, CT or MRI staging should be considered before surgery to remove the tumour (transurethral resection of bladder tumour, TURBT) if muscle-invasive bladder cancer is suspected at cystoscopy. More .... (Source: NHS Networks)
Source: NHS Networks - February 26, 2015 Category: UK Health Authors: Maria Axford Source Type: news
Miriam Hospital 1 of 3 New England hospitals using technology to detect, treat bladder cancer
(Lifespan) The Miriam Hospital is using a new minimally invasive technology that improves the ability for doctors to detect bladder cancer. Using blue-light cystoscopy, doctors instil an optical imaging agent into the bladder to detect abnormal growths or suspicious areas. The procedure is performed at the Minimally Invasive Urology Institute at The Miriam Hospital, the only hospital in Rhode Island to offer the treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2015 Category: Global & Universal Source Type: news
China Cystoscopes Market Outlook to 2020 Latest Industry Forecast...
ResearchMoz.us include new market research report"China Cystoscopes Market Outlook to 2020 " to its huge collection of research reports.Full Report @...(PRWeb July 27, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12047450.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2014 Category: Pharmaceuticals Source Type: news
Canada Endoscopy Visualization Systems Market Outlook to 2020:...
Market Resarch Reports.Biz includes new market research report "Canada Endoscopy Visualization Systems, Cystoscopes, Ureteroscopes, Laryngoscopes Market outlook to 2020" to its huge...(PRWeb July 26, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12047235.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 26, 2014 Category: Pharmaceuticals Source Type: news
Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast...
MarketOptimizer.org adds “Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Outlook to 2020” to its store. The data in the report is derived from dynamic market forecast models.(PRWeb July 25, 2014)Read the full story at http://www.prweb.com/releases/2020-canada-laryngoscopes/ureteroscopes-cystoscopes/prweb12047189.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 26, 2014 Category: Pharmaceuticals Source Type: news
Cystoscopy and Ureteroscopy
Title: Cystoscopy and UreteroscopyCategory: Procedures and TestsCreated: 9/17/2007 12:00:00 AMLast Editorial Review: 1/31/2014 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - January 31, 2014 Category: Anesthesiology Source Type: news
Cystoscopy imperative during female incontinence surgery
US researchers say that cystoscopy for lower urinary tract injury should be performed in all women undergoing urinary incontinence surgery, after finding that abnormalities are detected in one in 20 patients. (Source: MedWire News - Urology)
Source: MedWire News - Urology - January 27, 2014 Category: Urology & Nephrology Source Type: news
Hematuria Patients Rarely Referred for Cancer ScreeningHematuria Patients Rarely Referred for Cancer Screening
Guideline-recommended referrals for cystoscopy and imaging are very low, a new study has found. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2013 Category: Consumer Health News Tags: General Surgery News Source Type: news
LAVH for Fibroids and finally I can start living again! Sarah’s Story
I’m 46 years old, work full-time, have one daughter who is 20. I’m married to an Italian and live in Italy. I love sport. I am one of those people who is never ill! I’ve never taken one day sick in my life. About 4 years ago I started having really bad menstrual problems, haemorrages and if you’re on holiday it’s not funny. After becoming anaemic I finally decided to go to a gynaecologist who told me I had big fibroids and the best thing was a hysterectomy. I managed to convince them to implant a IUD that released progesterone and the bleeding reduced. Unfortunately in the last year my lifesty...
Source: The Hysterectomy Association - June 3, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Latest News Your Stories Fibroids laparascopic hysterectomy LAVH Source Type: news
New Test For Bladder Cancer Will Significantly Improve Quality Of Patient Care
A simple urine test, developed at the University of Surrey may greatly improve patient quality of life and has the potential to save the NHS in excess of Â£100 million every year. The test, developed by Dr Richard Morgan and Prof Hardev Pandha looks for traces of the EN -2 protein in the urine, a protein which has been found to exist in bladder and prostate cancer patients.Â� The test will help in the early detection of bladder cancer and could allow doctors to diagnose and treat patients without using invasive and costly procedures, such as cystoscopies... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 29, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
FDA Approves Botox for Overactive Bladder
Cystoscopic injection of Botox causes the bladder musculature to relax increasing the organ's storage capacity, and reducing episodes of urinary incontinence. (Source: Consultant Live)
Source: Consultant Live - January 28, 2013 Category: Primary Care Source Type: news